Name | Address | Scientific Field | |
| 1 | Dick Heinegård | Department of Experimental Medical Sciences, Lund University, SE-221 84 Lund, Sweden | Matrix Assebly, tissue homeostasis, structure-function of ECM |
| 2 | Naoyuki Taniguchi | Department of Disease Glycomics, Institute for Microbial Diseases, Osaka University, Suita, Osaka 567-0871, Japan | Glycobiology and disease targeting |
| 3 | Anne Delle | Division of Molecular Biosciences, Imperial College, London SW7 2AZ, United Kingdom | Glycomics and glycoproteomics |
| 4 | Dimitrios Kletsas | Laboratory of Cell Proliferation and Ageing, Institute of Biology, National Centre for Scientific Research "Demokritos", 153 10 Athens, Greece | Cellular senescence and signaling mechanisms in cancer |
| 5 | Fotini Lamari | Department of Pharmacy, Laboratory of Pharmacognosy and Chemistry of Natural Products, University of Patras, 26500 Patras, Greece | Structure and Biological Roles of Glycosaminoglycans |
| 6 | Alberto Passi | Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Universita degli Studi dell'Insubria, via J.H. Dunant 5, Varese 21100, Italy | Metabolic control of proteoglycans and pathobiology |
| 7 | Pauline Rudd | Dublín-Oxford Glycobiology laboratoty, NIBRT, Conway Institute, UCD, Dublín 4, Ireland | Biomarkers and glycosylated targets |
| 8 | Achilleas Theocharis | Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26110, Patras, Greece | Proteoglycans in Health and Diseases (multiple myeloma) |
| 9 | Vincent Hascall | Department of Biomedical Engineering, Lerner Research Institute ND-20, Cleveland Clinic Foundation, Cleveland, OH 44195, USA | Role of Hyaluronan in Inflammatory Proccesses |
| 10 | Nikos Karamanos | Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26110, Patras, Greece | Molecular Targets in Breast Cancer, Proteoglycans, Metalloproteinases, ER-signaling |
| 11 | Paraskevi Heldin | Ludwig Institute for Cancer Research, Uppsala University, Biomedical Center, Box 595, S-751 24 Uppsala, Sweden | Hyaluronan-CD44 Interaction and Hyaluronan Synthases |
| 12 | Israel Vlodavski | Cancer and Vascular and Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel | Heparanase in cancer metastasis and angiogenesis |
| 13 | Gillian Murphy | Cancer Research UK Cambridge Research Institute Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE | Metalloproteinases in matrix pathobiology |
| 14 | Raija Tammi | Department of Anatomy, University of Kuopio, P. O. Box 1627, FIN-70211 Kuopio, Finland | Matrix and epithelial tissues |
| 15 | Lena Kjellen | Department of Medical Biochemistry and Microbiology, Uppsala University, BMC, Box 582, SE-751 23 Uppsala, Sweden | Regulation of biosynthetic enzymes |
| 16 | Sibnath Ghatak | MUSK, Charleston, SC | CD44 in tumor progression |
| 17 | Jan-Olof Winberg | Department of Biochemistry, Institute of Medical Biology, University of Tromsø, Norway | Matrix complexes of MMPs-TIPMs – implication in diseases |
| 18 | Carl-Henrik Heldin | Ludwig Institute for Cancer Research Uppsala University | PDGF-R signaling and tumor therapy |
| 19 | Hideaki Nagase | Imperial College School of Medicine, London, United Kingdom | Action of Metalloproteinases/ tissue inhibitors – disease targeting |
| 20 | Evagelia Papadimitriou | Department of Pharmacy, Laboratory of Molecular Pharmacology, University of Patras, 26500 Patras, Greece | Heparin-Affin Binding Protein, Signaling and Angiogenesis |
| 21 | George Tzanakakis | Department of Anatomy, School of Medicine, University of Crete, Heraklion | Proteoglycans –signaling in cancer targeting |
| 22 | A.van Kuppevelt | Department of Biochemistry, Faculty of Medical Sciences, University of Nijmegen, Netherlands | Glycosaminoglycan pathobiology |
| 23 | John Couchman | Biomedicine Institute, University of Copenhagen, Biocenter Ole Maaloes Vej 5, 2200 Copenhagen N, Denmark | Integrins in cell adhesion and matrix-mediated signaling |
| 24 | Renato Iozzo | Thomas Jefferson University 1020 Locust Street , Room 249 JAH Philadelphia, PA 19107 | Proteoglycans as targets for molecular therapy |
| 25 | Jenny Karousou | Biomediche Sperimentali e Cliniche, Universita degli Studi dell'Insubria, via J.H. Dunant 5, Italy & University of Uppsala, Sweden | Ubiquitination of glycans and proteoglycans |
| 26 | Aris Moustakas | Ludwig Institute for Cancer Research, Box 595, SE-75124, Uppsala, Sweden | Signaling in epithelial-mesenchymal transition |
| 27 | Liliana Schaefer | Institute of Pharmacology, University of Frankfurt, Frankfurt am Main, Germany | SLRP-Signaling in Inflammation and Fibrosis |
| 28 | Marku Tammi | Departments of Biomedicine, University of Kuopio, Kuopio, Finland | Ηyaluronan synthesis and HAS promoter activation |
| 29 | Staffan Johansson | Dept. of Med. Biochem. and Microbiol., Uppsala University, Biomedical Center, Sweden | Integrins-mediated signaling |
| 30 | Sharona Even-Ram | The Stem Cell Center, Goldyne Savad Institute of Gene Therapy, Jerusalem, Israel | ECM and cytoskeletal aspects in stem cell pluripotency and early neural differentiation |
| 31 | Anders Hjerpe | Departments of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden | Mesothelioma proteoglycans |
